Looking Back On 2021
December 21, 2021
As the reality of living amongst a global pandemic set in across the world over the past year, a key highlight of 2021 was undoubtedly the rollout of life saving vaccines from AstraZeneca, Pfizer, Johnson and Johnson, and Moderna.

At Medlior, this was also a year of continued growth with new clients, projects, and colleagues. We feel very fortunate to have our business grow during this time, and a few of those highlights are noted below.

New Team Members

We are excited to have added a number of new colleagues to the Medlior team this year, including Jody Filkowski, Tram Pham, Nicole Robert, Adaeze Nwigwe, Kellie MacLean, Paul Spin, and Dat Tran. 

As a Research Lead and member of Medlior’s Management Team, we are excited to have Paul lead a range of RWE and evidence synthesis projects, while overseeing cross-functional data and analytics capabilities. Drawing on over ten years of experience across industry, academia and the public sector, Paul strives to provide technically robust, evidence-informed, patient-centred solutions to our clients.


2021 brough many opportunities for Medlior to share our research through virtual scientific conferences as well as peer-review journals. A select few are below, but for a complete list of publications check out our publications page.

  • Trends in Major Adverse Cardiac Events During the COVID-19 Pandemic in Alberta, Canada. American Heart Association Scientific Sessions 2021, November 13-15, 2021 (Virtual). Read More
  • COVID-19 Pandemic Induced Disruptions in Troponin and Low-Density Lipoprotein Cholesterol Laboratory Test Volumes Across Alberta. Canadian Congress of Cardiology, October 20-23, 2021 (Virtual). Read More.
  • Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study. Clin Cardiol. 2021. Read More 
  • Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, Canada, Journal of Medical Economics, 24:sup1, 51-59. Read More.
  • Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada. J Neuromuscul Dis. 2021;8(4):553-568. Read More.  

Medlior Graduate Scholarship for Women in Life Science

This year we were thrilled to announce the Medlior Graduate Scholarship for Women in Life Science in partnership with the University of Calgary. The annual scholarship will be awarded to students who self-identify as women, are registered full-time in a graduate degree program, and are pursuing research in the field of life sciences, global health, or patient care. 

As a women-owned life sciences company, this scholarship supports our commitment to promoting women in pursuit of advanced science degrees.

Charitable Contributions 

Medlior is very proud to support many outstanding non-profit organizations that seek to improve patient lives and those in need. In 2021, we were pleased to support The National Centre for Truth and Reconciliation, The Enbridge Ride to Conquer Cancer, The University of Alberta – Faculty of Native Studies, Movember, and UNICEF Canada #GIVEAVAX campaign.

As a festive gift, we were delighted to place a corporate and customized order for “The Giving Toque” from a Calgary-based company, and social enterprise, Local Laundry. For every toque that is purchased, they provide one to a shelter in need. This Canadian-made, sustainable, and eco-conscious toque is made from recycled pop bottles, also allowing us to contribute to a greener environment.

CADTH and ISPOR Conference Sponsorships

Medlior was pleased to be a sponsor and virtual exhibitor at the 2021 CADTH Symposium as well as the ISPOR Worldwide and EU conferences. 

These sponsorships are an important step in showcasing Medlior’s services to a global audience, and connecting with healthcare stakeholders around the world. We look forward to continuing to connect with global leaders in 2022 to discuss how we can promote sustainable health systems, improve patient lives, and realize the potential of new and emerging technologies.

Panelists for the Canadian Organization for Rare Disorders (CORD)

Throughout the year, the Medlior team are invited to contribute as panellists or speakers across a variety of life sciences events. A highlight this year was Medlior’s founder Tara Cowling, and Principal Suzanne McMullen, who were invited to join as panellists at two of the CORD Webinars, focusing on their expertise in utilizing RWE to inform decision-making.

Looking forward

The Medlior team is excited to launch into 2022 and continue our collaborative research studies that will positively impact patient care worldwide. We will be announcing additional team members early in the new year, who will bring further expertise and value to our research studies. 

In the meantime, we look forward to closing our virtual doors on December 24th and re-opening on January 4th with a refreshed and reenergized team!

From our team to yours, we wish you a healthy holiday season and all of the best in the New Year!